After 2 weeks of treatment, mice treated with GLP-1MK-801, as well as those subjected to calorie restriction or GLP-1 monotherapy, demonstrated enhanced glucose tolerance compared with mice that were treated with the vehicle or MK-801 monotherapy (Extended Data Fig
Conceio-Furber, E., Coskun, T., Sloop, K
While pharmaceutical research explores advanced transdermal delivery systems using microneedles, iontophoresis, or chemical enhancers, these technologies remain experimental for GLP-1 delivery and are not present in consumer patch products
Weeks 1 to 4: 20 units (0.2 mL) once weekly Weeks 5 to 8: 40 units (0.4 mL) once weekly Weeks 9 to 12: 70 units (0.7 mL) once weekly Weeks 13 to 16: 90 units (0.9 mL) once weekly These are unit measurements based on insulin syringe markings